<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Written evidence submitted by The Royal Society of Chemistry (RaD0010)</title></head><body><div><p style="margin:0pt 0pt 7.2pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written evidence submitted by </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">The Royal Society of Chemistry (RaD0010)</span></p><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The Royal Society of Chemistry is the world’s leading chemistry </span><span style="font-family:'Times New Roman'; font-size:11pt">community, advancing excellence in the chemical sciences. With 48,000 members and a knowledge business that spans the globe, we are the UK’s professional body for chemical scientists; a not-for-profit organisation with over 170 years of history and an inte</span><span style="font-family:'Times New Roman'; font-size:11pt">rnational vision of the future. We promote, support and celebrate chemistry. We work to shape the future of the chemical sciences – for the benefit of science and humanity.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">T</span><span style="font-family:'Times New Roman'; font-size:11pt">he Royal Society of Chemistry (RSC) welcomes the opportunity to comment on Researc</span><span style="font-family:'Times New Roman'; font-size:11pt">h and Development (R&amp;D) funding for science and technology in the UK.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Possible </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Future Inquiries on UK R&amp;D Funding.</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Long-term planning.</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Times New Roman'; font-size:11pt">Prior to the </span><span style="font-family:'Times New Roman'; font-size:11pt">2013 Spending Round a number of calls were made for a long-term strategy for science funding as it was beli</span><span style="font-family:'Times New Roman'; font-size:11pt">eved that this would encourage inward investment, and encourage researchers to remain in the UK. This call was in part answered by the announcement of a trajectory for the scienc</span><span style="font-family:'Times New Roman'; font-size:11pt">e capital budget up until 2020-1</span><span style="font-family:'Times New Roman'; font-size:11pt">. It would be of use for the </span><span style="font-family:'Times New Roman'; font-size:11pt">Select C</span><span style="font-family:'Times New Roman'; font-size:11pt">ommittee </span><span style="font-family:'Times New Roman'; font-size:11pt">to consider the </span><span style="font-family:'Times New Roman'; font-size:11pt">impacts</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> on</span><span style="font-family:'Times New Roman'; font-size:11pt"> researchers, businesses, and the UK, of a long-term strategy (or lack there-of). </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">In </span><span style="font-family:'Times New Roman'; font-size:11pt">light of the </span><span style="font-family:'Times New Roman'; font-size:11pt">target of 3% of GDP to be invested in R&amp;D</span><span style="font-family:'Times New Roman'; font-size:11pt"> as set in the </span><span style="font-family:'Times New Roman'; font-size:11pt">EU’s 2020 strategy</span><span style="font-family:'Times New Roman'; font-size:11pt">, </span><span style="font-family:'Times New Roman'; font-size:11pt">and the fact that m</span><span style="font-family:'Times New Roman'; font-size:11pt">any</span><span style="font-family:'Times New Roman'; font-size:11pt"> EU countries have a fixed targe</span><span style="font-family:'Times New Roman'; font-size:11pt">t for increasing R&amp;D intensity, </span><span style="font-family:'Times New Roman'; font-size:11pt">we recommend the Select Committee investigate</span><span style="font-family:'Times New Roman'; font-size:11pt"> whether the UK should take a similar approach to R&amp;D in order to help drive innovation. </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Measuring Innovation</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">. </span><span style="font-family:'Times New Roman'; font-size:11pt">The metrics used to measure national success in innovation could be</span><span style="font-family:'Times New Roman'; font-size:11pt"> co</span><span style="font-family:'Times New Roman'; font-size:11pt">nsidered and compared across funding and rating bodies. </span><span style="font-family:'Times New Roman'; font-size:11pt">The NAO review notes that ‘R&amp;D is historically the most cited metric of innovation in an economy.’ </span><span style="font-family:'Times New Roman'; font-size:11pt">Since innovation is not the same as development, it would be worthwhile</span><span style="font-family:'Times New Roman'; font-size:11pt"> for the committee to consi</span><span style="font-family:'Times New Roman'; font-size:11pt">der what metrics </span><span style="font-family:'Times New Roman'; font-size:11pt">are appropriate for assessing the environment, and capacity, for innovation aside from R&amp;D spend, alongside how the UK performs internationally by these measures</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">The abolishment of the UK R&amp;D Scoreboard has removed a key source of this in</span><span style="font-family:'Times New Roman'; font-size:11pt">formation and the impact of this decision should be considered.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">A further issue on R&amp;D intensity may be to investigate what the relative merits are of using R&amp;D intensity as a tool to compare nations. A similar investigative approach could also be useful i</span><span style="font-family:'Times New Roman'; font-size:11pt">n determining how effective the list of top global innovators is at determining the overall rate of innovation within a country.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The role of SMEs in undertaking private sector R&amp;D is becoming increasingly important, and because of this an area for investig</span><span style="font-family:'Times New Roman'; font-size:11pt">ation may be the </span><span style="font-family:'Times New Roman'; font-size:11pt">appropriateness of the UK’s support mechanisms for this changing environment. </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">S</span><span style="font-family:'Times New Roman'; font-size:11pt">ection 1.1 of the NAO review </span><span style="font-family:'Times New Roman'; font-size:11pt">identified</span><span style="font-family:'Times New Roman'; font-size:11pt"> that the rate of return for investment in R&amp;D was between 20% and 50%. It would be </span><span style="font-family:'Times New Roman'; font-size:11pt">useful to identify what</span><span style="font-family:'Times New Roman'; font-size:11pt"> more could b</span><span style="font-family:'Times New Roman'; font-size:11pt">e done to commercialise research and bring innovative technologies to market</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and what the current strengths, weaknesses, opportunities and threats for the UK are in driving the commercialisation of R&amp;D.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Given that the intention of the Patent Box was to en</span><span style="font-family:'Times New Roman'; font-size:11pt">courage investment in research and innovation in the UK, we suggest that the committee investigate, at the earliest opportunity, what effect it has had (or is currently projected to have) upon innovation, and whether it is a successful tax incentive for en</span><span style="font-family:'Times New Roman'; font-size:11pt">couraging companies to undertake R&amp;D within the UK.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:113%; margin:5pt 0pt 0pt 17.85pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The UK has several mechanisms for supporting R&amp;D, in part by the Research Councils and in part by the Technology Strategy Board. The committee might like to understand how coherent the approaches of the v</span><span style="font-family:'Times New Roman'; font-size:11pt">arious agencies are, and what, if any, coherence and interaction exists with major European funding initiatives such as FP7 and Horizon 2020</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 17.85pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Research Concentration</span><span style="font-family:'Times New Roman'; font-size:11pt">. The NAO report highlighted significant regional imbalance in levels of public and private R</span><span style="font-family:'Times New Roman'; font-size:11pt">&amp;D funding. The committee</span><span style="font-family:'Times New Roman'; font-size:11pt"> might wish to examine</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">this issue as well as the </span><span style="font-family:'Times New Roman'; font-size:11pt">mechanics to ensure balance of research concentration to the need for broad capacity. The benefits of innovation clusters </span><span style="font-family:'Times New Roman'; font-size:11pt">for the research within the cluster </span><span style="font-family:'Times New Roman'; font-size:11pt">are often cited, but the</span><span style="font-family:'Times New Roman'; font-size:11pt"> dual roles of H</span><span style="font-family:'Times New Roman'; font-size:11pt">igher </span><span style="font-family:'Times New Roman'; font-size:11pt">E</span><span style="font-family:'Times New Roman'; font-size:11pt">ducation </span><span style="font-family:'Times New Roman'; font-size:11pt">I</span><span style="font-family:'Times New Roman'; font-size:11pt">nstitute</span><span style="font-family:'Times New Roman'; font-size:11pt"> staff as teachers and researchers, and the job creation potential of high-tech companies mean that a balancing </span><span style="font-family:'Times New Roman'; font-size:11pt">point</span><span style="font-family:'Times New Roman'; font-size:11pt"> and means of maintaining equilibrium need to be found. </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 7.2pt 17.85pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The distribution of </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D </span><span style="font-family:'Times New Roman'; font-size:11pt">across</span><span style="font-family:'Times New Roman'; font-size:11pt"> industry s</span><span style="font-family:'Times New Roman'; font-size:11pt">ectors </span><span style="font-family:'Times New Roman'; font-size:11pt">would additionally be an area for the Select Committee’s focus. The NAO report highlights the concentration of private sector R&amp;D within the pharmaceutica</span><span style="font-family:'Times New Roman'; font-size:11pt">l sector particularly, and just 2 companies within that sector. The</span><span style="font-family:'Times New Roman'; font-size:11pt"> risks </span><span style="font-family:'Times New Roman'; font-size:11pt">of this </span><span style="font-family:'Times New Roman'; font-size:11pt">concentrat</span><span style="font-family:'Times New Roman'; font-size:11pt">ion</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">along with mechanisms for </span><span style="font-family:'Times New Roman'; font-size:11pt">mitigat</span><span style="font-family:'Times New Roman'; font-size:11pt">ion and diversification should be investigated</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 7.2pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Research </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Spillover</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span><span style="font-family:'Times New Roman'; font-size:11pt">As a large number of S</span><span style="font-family:'Times New Roman'; font-size:11pt">cience, </span><span style="font-family:'Times New Roman'; font-size:11pt">T</span><span style="font-family:'Times New Roman'; font-size:11pt">echnology, </span><span style="font-family:'Times New Roman'; font-size:11pt">E</span><span style="font-family:'Times New Roman'; font-size:11pt">ngineering and </span><span style="font-family:'Times New Roman'; font-size:11pt">M</span><span style="font-family:'Times New Roman'; font-size:11pt">athematics (STEM)</span><span style="font-family:'Times New Roman'; font-size:11pt"> gradua</span><span style="font-family:'Times New Roman'; font-size:11pt">tes take up jobs in sectors out</span><span style="font-family:'Times New Roman'; font-size:11pt">with science and engineering (e.g. fina</span><span style="font-family:'Times New Roman'; font-size:11pt">ncial services), an inquiry looking at the broader benefits of funding scientific research may be insightful</span><span style="font-family:'Times New Roman'; font-size:11pt">, and help recognise the importance of support for STEM education and research</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Comments on the UK Government’s 2010 </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">S</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">pending</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold"> Review.</span></p><ol start="14" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The R</span><span style="font-family:'Times New Roman'; font-size:11pt">oyal </span><span style="font-family:'Times New Roman'; font-size:11pt">S</span><span style="font-family:'Times New Roman'; font-size:11pt">ociety of </span><span style="font-family:'Times New Roman'; font-size:11pt">C</span><span style="font-family:'Times New Roman'; font-size:11pt">hemistry</span><span style="font-family:'Times New Roman'; font-size:11pt"> welcomed the government's decision to prioritise science in the 2010 Comprehensive Spending Review</span><span style="font-family:'Times New Roman'; font-size:11pt"> (CSR)</span><span style="font-family:'Times New Roman'; font-size:11pt"> and the recognition that protecting the research budget was</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and continues to be</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> vital to reviving the UK's economy.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">We were</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">howev</span><span style="font-family:'Times New Roman'; font-size:11pt">er </span><span style="font-family:'Times New Roman'; font-size:11pt">disappointed that the CSR did not recognise the </span><span style="font-family:'Times New Roman'; font-size:11pt">importance of</span><span style="font-family:'Times New Roman'; font-size:11pt"> capital expenditure </span><span style="font-family:'Times New Roman'; font-size:11pt">with </span><span style="font-family:'Times New Roman'; font-size:11pt">funding available for </span><span style="font-family:'Times New Roman'; font-size:11pt">initially</span><span style="font-family:'Times New Roman'; font-size:11pt"> reduced</span><span style="font-family:'Times New Roman'; font-size:11pt"> by 41% in real terms.</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Times New Roman'; font-size:7.33pt; vertical-align:super">,</span><a name="_ftnref2"></a><a href="#_ftn2">[2]</a><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">We were</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">hence </span><span style="font-family:'Times New Roman'; font-size:11pt">relieved that the importance of capital was subsequently recognised by government and a</span><span style="font-family:'Times New Roman'; font-size:11pt"> number of injections of funding announced on top of the CSR 2010 settlement.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></li></ol><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Comments on the UK Government’s 2013 Spending R</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">ound</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">.</span></p><ol start="15" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The Royal Society of Chemistry was broadly pleased with the outcome of the 2013 Spending Review for science when s</span><span style="font-family:'Times New Roman'; font-size:11pt">et in the</span><span style="font-family:'Times New Roman'; font-size:11pt"> context of the Government’s plan for ave</span><span style="font-family:'Times New Roman'; font-size:11pt">rage departmental cuts of</span><span style="font-family:'Times New Roman'; font-size:11pt"> 10%</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">T</span><span style="font-family:'Times New Roman'; font-size:11pt">he return of capital spending to 2010 levels and a long term commitment to sustain this in real terms was a welcome step forward</span><span style="font-family:'Times New Roman'; font-size:11pt">. This </span><span style="font-family:'Times New Roman'; font-size:11pt">will provide long term </span><span style="font-family:'Times New Roman'; font-size:11pt">confidence</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">in</span><span style="font-family:'Times New Roman'; font-size:11pt"> the </span><span style="font-family:'Times New Roman'; font-size:11pt">UK’s s</span><span style="font-family:'Times New Roman'; font-size:11pt">upport </span><span style="font-family:'Times New Roman'; font-size:11pt">for</span><span style="font-family:'Times New Roman'; font-size:11pt"> scientific </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">and </span><span style="font-family:'Times New Roman'; font-size:11pt">has the potential to</span><span style="font-family:'Times New Roman'; font-size:11pt"> attract </span><span style="font-family:'Times New Roman'; font-size:11pt">further </span><span style="font-family:'Times New Roman'; font-size:11pt">private sector</span><span style="font-family:'Times New Roman'; font-size:11pt"> investment</span><span style="font-family:'Times New Roman'; font-size:11pt"> in R&amp;D.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">We</span><span style="font-family:'Times New Roman'; font-size:11pt"> ha</span><span style="font-family:'Times New Roman'; font-size:11pt">ve</span><span style="font-family:'Times New Roman'; font-size:11pt"> been calling on the government to look into methods of consolidating</span><span style="font-family:'Times New Roman'; font-size:11pt"> innovation mechanisms in order to help turn innovation into growth</span><a name="_ftnref3"></a><a href="#_ftn3">[3]</a><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">and</span><span style="font-family:'Times New Roman'; font-size:11pt"> w</span><span style="font-family:'Times New Roman'; font-size:11pt">ere</span><span style="font-family:'Times New Roman'; font-size:11pt"> therefore</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">pleased to see the government</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">increase their support for the TSB by providing an additional £185m in the spending review.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Despite the positive steps taken by the government in this latest spending review, </span><span style="font-family:'Times New Roman'; font-size:11pt">we</span><span style="font-family:'Times New Roman'; font-size:11pt"> continue to advocate for a long-term</span><span style="font-family:'Times New Roman'; font-size:11pt"> and sustained investment in the UK science base and </span><span style="font-family:'Times New Roman'; font-size:11pt">remain</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">concerned by </span><span style="font-family:'Times New Roman'; font-size:11pt">a long-term </span><span style="font-family:'Times New Roman'; font-size:11pt">continu</span><span style="font-family:'Times New Roman'; font-size:11pt">ation of the</span><span style="font-family:'Times New Roman'; font-size:11pt"> spending freeze</span><span style="font-family:'Times New Roman'; font-size:11pt"> on the science budget.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">T</span><span style="font-family:'Times New Roman'; font-size:11pt">his continued freeze amounts to real-terms cut of </span><span style="font-family:'Times New Roman'; font-size:11pt">over </span><span style="font-family:'Times New Roman'; font-size:11pt">10% between 2010 and 201</span><span style="font-family:'Times New Roman'; font-size:11pt">6</span><span style="font-family:'Times New Roman'; font-size:11pt">. The </span><span style="font-family:'Times New Roman'; font-size:11pt">full impact of this freez</span><span style="font-family:'Times New Roman'; font-size:11pt">e has not yet been seen, but is already apparent in</span><span style="font-family:'Times New Roman'; font-size:11pt"> reduced numbers of grants awarded by research councils – narrowing the research base upon which innovation can prosper – and reduced numbers of PhD </span><span style="font-family:'Times New Roman'; font-size:11pt">places awarded</span><span style="font-family:'Times New Roman'; font-size:11pt"> – decreasing the number of ‘coal face’ re</span><span style="font-family:'Times New Roman'; font-size:11pt">searchers</span><span style="font-family:'Times New Roman'; font-size:11pt">, and those upon whom future innovation will depend</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">UK public spending on R&amp;D has been declining relative to </span><span style="font-family:'Times New Roman'; font-size:11pt">its </span><span style="font-family:'Times New Roman'; font-size:11pt">competitors</span><span style="font-family:'Times New Roman'; font-size:11pt"> over past decades</span><span style="font-family:'Times New Roman'; font-size:11pt">, and now lies at only 0.57% of GDP, noticeably lower than the averages of 0.7% for the EU-27, and 0.8% </span><span style="font-family:'Times New Roman'; font-size:11pt">for the G8 and the OECD.</span><span style="font-family:'Times New Roman'; font-size:7.33pt; vertical-align:super">4</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The UK is not in a position to be internationally competitive whilst funding </span><span style="font-family:'Times New Roman'; font-size:11pt">of </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D at a level significantly </span><span style="font-family:'Times New Roman'; font-size:11pt">below</span><span style="font-family:'Times New Roman'; font-size:11pt"> that of its competitors. Long</span><span style="font-family:'Times New Roman'; font-size:11pt">-term investment in science is required to</span><span style="font-family:'Times New Roman'; font-size:11pt"> ensure that the UK is not left behind in th</span><span style="font-family:'Times New Roman'; font-size:11pt">e global race, and will provide a secure research ecosystem to attract business investment and top-class researchers.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Investment is needed from both public and private sources, but </span><span style="font-family:'Times New Roman'; font-size:11pt">both </span><span style="font-family:'Times New Roman'; font-size:11pt">academic research</span><a name="_ftnref4"></a><a href="#_ftn4">[4]</a><span style="font-family:'Times New Roman'; font-size:11pt"> and international comparisons</span><a name="_ftnref5"></a><a href="#_ftn5">[5]</a><span style="font-family:'Times New Roman'; font-size:11pt"> show that these two </span><span style="font-family:'Times New Roman'; font-size:11pt">are complementary and positively correlated.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The </span><span style="font-family:'Times New Roman'; font-size:11pt">RSC </span><span style="font-family:'Times New Roman'; font-size:11pt">urge</span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt"> the </span><span style="font-family:'Times New Roman'; font-size:11pt">government </span><span style="font-family:'Times New Roman'; font-size:11pt">to introduce </span><span style="font-family:'Times New Roman'; font-size:11pt">a long term plan to raise UK science spending to 0.7% of GDP (the current EU average) by the end of the next Parliament in 2020. This would </span><span style="font-family:'Times New Roman'; font-size:11pt">not </span><span style="font-family:'Times New Roman'; font-size:11pt">be an insignificant rise,</span><span style="font-family:'Times New Roman'; font-size:11pt"> but </span><span style="font-family:'Times New Roman'; font-size:11pt">is achievable, requiring </span><span style="font-family:'Times New Roman'; font-size:11pt">a 3% year-on-year increase in spending relative to GDP</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and would be a valuable investment for the long term success of the UK economy</span><span style="font-family:'Times New Roman'; font-size:11pt"> and science base</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Comments on the National Audit Office’s (NAO) review of R&amp;D funding</span></p><ol start="23" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The</span><span style="font-family:'Times New Roman'; font-size:11pt"> NAO’s review of R&amp;D funding for science and technology in the UK</span><a name="_ftnref6"></a><a href="#_ftn6">[6]</a><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">(the NAO review) </span><span style="font-family:'Times New Roman'; font-size:11pt">is comprehensive</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">It</span><span style="font-family:'Times New Roman'; font-size:11pt"> provides an informative overview of how science and technology is funded within the UK</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">the origin and value of the various sectors </span><span style="font-family:'Times New Roman'; font-size:11pt">that fund R&amp;D</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and </span><span style="font-family:'Times New Roman'; font-size:11pt">the sectors and industries that undertake R&amp;D</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">It is concerning to note the high level of dependency of UK private R&amp;D upon just a single sector, pharmaceuticals, and specifically upon just two companies within that sector. </span><span style="font-family:'Times New Roman'; font-size:11pt">The </span><span style="font-family:'Times New Roman'; font-size:11pt">committee</span><span style="font-family:'Times New Roman'; font-size:11pt"> would be well plac</span><span style="font-family:'Times New Roman'; font-size:11pt">ed to investigate any barriers to diversifying this research base.</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">SMEs are playing an ever increasing role in driving innovation in the UK economy. This is typified by the decline in traditional pharmaceutical company employment, and an increase in small </span><span style="font-family:'Times New Roman'; font-size:11pt">and medium biotech companies</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The RSC has long been arguing that investment in science, and R&amp;D in general, will stimulate economic growth. It is therefore noteworthy that “since 2005, other countries’ Higher Education Institutions have increased their sp</span><span style="font-family:'Times New Roman'; font-size:11pt">ending on undertaking R&amp;D at a faster rate than the UK [and] could reflect the increasing emphasis that some countries are placing on Higher Education as a way to rebalance their economies and recover from recession”</span><a name="_ftnref7"></a><a href="#_ftn7">[7]</a></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:6pt 0pt 0pt 18pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">In section 4.1 </span><span style="font-family:'Times New Roman'; font-size:11pt">of the NAO review, it was noted </span><span style="font-family:'Times New Roman'; font-size:11pt">that the UK is amongst a very small number of </span><span style="font-family:'Times New Roman'; font-size:11pt">European Union member states that ha</span><span style="font-family:'Times New Roman'; font-size:11pt">ve</span><span style="font-family:'Times New Roman'; font-size:11pt"> not adopted national </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D intensity targets and that the EU’s strategy for growth includes a target to invest 3% of GDP in R&amp;D by 2020.</span><span style="font-family:'Times New Roman'; font-size:11pt"> This</span><span style="font-family:'Times New Roman'; font-size:11pt"> should be viewed alongside the recent report produced at BIS, showing the importance of long term targets in convincing global companies to invest in the UK.</span><a name="_ftnref8"></a><a href="#_ftn8">[8]</a></li></ol><p style="font-size:11pt; line-height:115%; margin:6pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">August 2013</span></p><p style="margin:0pt 0pt 7.2pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:Calibri; font-size:10pt"> </span><span style="font-family:Calibri; font-size:10pt">Science Campaign, 2010 </span><a href="http://sciencecampaign.org.uk/?p=2606"><span style="color:#0000ff; font-family:Calibri; font-size:10pt; text-decoration:underline">http://sciencecampaign.org.uk/?p=2606</span></a><span style="font-family:Calibri; font-size:10pt"> </span></p><p style="margin:0pt"><a name="_ftn2"></a><a href="#_ftnref2">[2]</a><span style="font-family:Calibri; font-size:10pt"> </span><span style="font-family:Calibri; font-size:10pt">Financial Times, 2010 </span><a href="http://www.ft.com/cms/s/2/59dc8108-0c6b-11e0-8408-00144feabdc0.htm"><span style="color:#0000ff; font-family:Calibri; font-size:10pt; text-decoration:underline">http://www.ft.com/cms/s/2/59dc8108-0c6b-11e0-8408-00144feabd</span><span style="color:#0000ff; font-family:Calibri; font-size:10pt; text-decoration:underline">c0.htm</span></a><span style="font-family:Calibri; font-size:10pt"> </span></p><p style="margin:0pt"><a name="_ftn3"></a><a href="#_ftnref3">[3]</a><span style="font-family:Calibri; font-size:10pt"> </span><a href="http://www.rsc.org/images/campaign_case_studies_tcm18-232087.pdf"><span style="color:#0000ff; font-family:Calibri; font-size:10pt; text-decoration:underline">Creating growth by staying ahead in science</span></a><span style="font-family:Calibri; font-size:10pt">, Royal Society of Chemistry, 2013</span></p><p style="margin:0pt"><a name="_ftn4"></a><a href="#_ftnref4">[4]</a><span style="font-family:Calibri; font-size:10pt"> </span><a href="http://martin.falk.wifo.ac.at/fileadmin/homepage_falk/files/Falk_2006_RAEF_A_139101.pdf"><span style="color:#0000ff; font-family:Calibri; font-size:10pt; text-decoration:underline">Falk, M, Applied Economics</span></a><span style="font-family:Calibri; font-size:10pt">, 38, 533-547 (2006)</span></p><p style="margin:0pt"><a name="_ftn5"></a><a href="#_ftnref5">[5]</a><span style="font-family:Calibri; font-size:10pt"> </span><span style="font-family:Calibri; font-size:10pt">Main Science and Technology Indicators,</span><span style="font-family:Calibri; font-size:10pt"> OECD</span><span style="font-family:Calibri; font-size:10pt"> </span><span style="font-family:Calibri; font-size:10pt">(</span><span style="font-family:Calibri; font-size:10pt">2013</span><span style="font-family:Calibri; font-size:10pt">)</span></p><p style="margin:0pt"><a name="_ftn6"></a><a href="#_ftnref6">[6]</a><span style="font-family:Calibri; font-size:10pt"> Research and Development funding for science and technology in the UK, National Audit Office, 2013</span></p><p style="margin:0pt"><a name="_ftn7"></a><a href="#_ftnref7">[7]</a><span style="font-family:Calibri; font-size:10pt"> Research and Development funding for science and technology in the UK, National Audit Office, 2013</span></p><p style="margin:0pt"><a name="_ftn8"></a><a href="#_ftnref8">[8]</a><span style="font-family:Calibri; font-size:10pt"> </span><a href="http://www.rcuk.ac.uk/documents/documents/LeverageReport.pdf"><span style="color:#0000ff; font-family:Calibri; font-size:10pt; text-decoration:underline">Leverage from public funding of science and research</span></a><a name="_GoBack"></a><span style="font-family:Calibri; font-size:10pt">, Department for Business</span><span style="font-family:Calibri; font-size:10pt"> Innovation &amp; Skills, 2013</span></p></body></html>